click on his name, then click on "ALL"
he doesn't seem to post office and at a quick glance it looks like he was also in IMGN in 2010
he's a mystery man
No idea where this is coming from but I can with 100% certainty say it is NOT coming from the conference. They are very strict about when the electronic links QR codes to the posters are made available. Unless he s an employee of SNTA or an author or somehow privy to sensitive data before the public is.
Totally fake. I'm going to the posters later this evening. Sometimes investigators that have posters early the next morning put up the evening before. I doubt it but will check.
I would say 6 out of 10 patients will show PR with a trend to improved results over time - tumor shrinks more the more time it is on the therapy. Specifically the patients showing mPR and mSD with tumor shrinkage are highly likely to be responsive and their response will increase over time of treatment. That was 6 out of the initial 10. The 1 PD and 3SD without metabolic response are non-responders and will progress.
The patients who show metabolic response benefit and that benefit will grow over time. The 6 week partial response is impressive and we know at 12 weeks we had 4PR's and 5SD's all of which showed metabolic activity out of 15.
Promising activity of Ganetespib in Breast cancer:
In the 10 patients with evaluable PET imaging, 9 patients achieved metabolic (m) response (2 mPR, 4 mSD with dominant tumor shrinkage and 3 SD) and one patient with mPD. In the 6 patients evaluable for OR at wk 6, one patient achieved PR, 2 SD
I'm at the conference but unfortunately Synta does not have a medical booth. I've snooped around but nothing specific or actionable regarding the anticipated results yet. The abstract is embargoed till tomorrow,
Adam Feuerstein is bashing NWBO right now. You might get a great price tomorrow at the open...
NWBO was down big in AH. It dropped to 3.23 but is coming back. Still it is down 11-12%. Depending on how it opens tomorrow it might be a good play. I had no funds to play with when it was at 3.24 otherwise I would have hit it hard.
NWBO is down an additional 11.36% in the AH
time will tell on NWBO though... they are on my 2014 watch list
Oh haha. I think if that abstract that was posted on here is legit it will be a rocket ship tomorrow morning and it will continue through Friday ala Kerx results. Will update this prediction when I see the data tomorrow morning.
Ouch is right. I wonder what that means for NWBO. I imagine lower prices in the short term. I think NWBO's approach will yield more impressive results. There is a big difference between activating for a generic set of antigens and activating the dendritic cells for a specific cancer. That is the difference and I think it will surprise people next year.
I feel as though the price will peak on Friday or Monday and not tomorrow. Not sure why... just a gut feeling. I could be wrong. I could be right.
I have my eyes open for the next press release. It should be wonderful. Cool.
Sentiment: Strong Buy